These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7502746)

  • 1. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection.
    Sweet SP; Challacombe SJ; Naglik JR
    Adv Exp Med Biol; 1995; 371B():1031-4. PubMed ID: 7502746
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
    Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
    Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.
    Savage NW; Barnard K; Shirlaw PJ; Rahman D; Mistry M; Escudier MP; Sanderson JD; Challacombe SJ
    Clin Exp Immunol; 2004 Mar; 135(3):483-9. PubMed ID: 15008983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis.
    Jeganathan S; Ufomata D; Hobkirk JA; Ivanyi L
    Clin Exp Immunol; 1987 Nov; 70(2):316-21. PubMed ID: 3322616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.
    Coogan MM; Sweet SP; Challacombe SJ
    Infect Immun; 1994 Mar; 62(3):892-6. PubMed ID: 8112860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects.
    Belazi M; Fleva A; Drakoulakos D; Panayiotidou D
    Int J STD AIDS; 2002 Jun; 13(6):373-7. PubMed ID: 12015010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva.
    Sweet SP; Rahman D; Challacombe SJ
    Immunology; 1995 Dec; 86(4):556-9. PubMed ID: 8567021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary and mucosal immune responses to HIV and its co-pathogens.
    Challacombe SJ; Sweet SP
    Oral Dis; 1997 May; 3 Suppl 1():S79-84. PubMed ID: 9456663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of a parotid salivary immunity reaction during chronic oral candidiasis (author's transl)].
    Scheffer P; Houin R; Deniau M; Cazin A; Mautaint CJ
    Rev Stomatol Chir Maxillofac; 1979; 80(6):354-8. PubMed ID: 394293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization against mucosal candidiasis in a mouse model.
    Rahman D; Challacombe SJ
    Adv Exp Med Biol; 1995; 371B():1663-6. PubMed ID: 7502878
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of age on immunoglobulin A subclass distribution in human parotid saliva.
    Childers NK; Greenleaf C; Li F; Dasanayake AP; Powell WD; Michalek SM
    Oral Microbiol Immunol; 2003 Oct; 18(5):298-301. PubMed ID: 12930521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients.
    Millon L; Drobacheff C; Piarroux R; Monod M; Reboux G; Laurent R; Meillet D
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):137-44. PubMed ID: 11242180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropism-restricted neutralization by secretory IgA from parotid saliva of HIV type 1-infected individuals.
    Wu X; Hall S; Jackson S
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):275-81. PubMed ID: 12804003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of HIV infection on oral mucosal immunity.
    Challacombe SJ; Naglik JR
    Adv Dent Res; 2006 Apr; 19(1):29-35. PubMed ID: 16672546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection.
    Cartry O; Moja P; Quesnel A; Pozzetto B; Lucht FR; Genin C
    Clin Exp Immunol; 1997 Jul; 109(1):47-53. PubMed ID: 9218823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Candida salivary immunoglobulins. Evidence of a specific local immune reaction (author's transl)].
    Scheffer P; Cazin A; Deniau M; Mautaint JC
    Rev Stomatol Chir Maxillofac; 1981; 82(2):136-9. PubMed ID: 7013016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA subclasses and molecular size in children with vertically transmitted HIV infection.
    Mascart-Lemone F; Levy J; Depelchin S; Dehennin JP; Cooman R; Sibille Y; Vaerman JP
    Adv Exp Med Biol; 1995; 371B():1007-10. PubMed ID: 7502740
    [No Abstract]   [Full Text] [Related]  

  • 18. Both IgA subclasses are reduced in parotid saliva from patients with AIDS.
    Müller F; Frøland SS; Hvatum M; Radl J; Brandtzaeg P
    Clin Exp Immunol; 1991 Feb; 83(2):203-9. PubMed ID: 1899629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine profiles in parotid saliva from HIV-1-infected individuals: changes associated with opportunistic infections in the oral cavity.
    Black KP; Merrill KW; Jackson S; Katz J
    Oral Microbiol Immunol; 2000 Apr; 15(2):74-81. PubMed ID: 11155169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid.
    Fukushima C; Matsuse H; Saeki S; Kawano T; Machida I; Kondo Y; Kohno S
    J Asthma; 2005 Sep; 42(7):601-4. PubMed ID: 16169797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.